PI3k inhibitors (BKM120 and BYL719) as radiosensitizers for head and neck squamous cell carcinoma during radiotherapy

• Fu-Cheng Chuang,

  Roles Data curation, Formal analysis, Methodology, Writing – original draft

  Affiliations Department of Radiation Oncology, E-Da Hospital, Kaohsiung, Taiwan, Department of Medicine, School of Medicine, I-Shou University, Kaohsiung, Taiwan

  ⨯
• Chih-Chun Wang,

  Roles Investigation, Methodology

  Affiliations Department of Medicine, School of Medicine, I-Shou University, Kaohsiung, Taiwan, Department of Otolaryngology, E-Da Hospital, Kaohsiung, Taiwan

  ⨯
• Jian-Han Chen,

  Roles Investigation, Methodology, Writing – review & editing

  Affiliations Department of Medicine, School of Medicine, I-Shou University, Kaohsiung, Taiwan, Department of General Surgery, E-Da Hospital, Kaohsiung, Taiwan

  ⨯
• Tzer-Zen Hwang,

  Roles Investigation, Methodology, Validation

  Affiliations Department of Medicine, School of Medicine, I-Shou University, Kaohsiung, Taiwan, Department of Otolaryngology, E-Da Hospital, Kaohsiung, Taiwan

  ⨯
• Shyh-An Yeh,

  Roles Investigation, Validation

  Affiliations Department of Radiation Oncology, E-Da Hospital, Kaohsiung, Taiwan, Department of Medical Imaging and Radiological Sciences, I-Shou University, Kaohsiung City, Taiwan

  ⨯
• Yu-Chieh Su

  Roles Conceptualization, Supervision, Writing – original draft, Writing – review & editing

  * E-mail: hepatoma@gmail.com

  Affiliations Department of Medicine, School of Medicine, I-Shou University, Kaohsiung, Taiwan, Division of Hematology-Oncology, Department of Internal Medicine, E-Da Hospital, Kaohsiung, Taiwan

  https://orcid.org/0000-0002-1771-9017

  ⨯